ESR1 and colorectal carcinoma: As patients with UC have a higher risk for colorectal carcinoma (CRC) development [31] and the estrogen receptors (ER) alpha/beta balance has a relevant influence on colorectal carcinogenesis [32], we then speculated that the dysregulation of estrogen signaling might be associated with the risk of colorectal carcinogenesis.